Synchronous second primary cancers in patients with squamous esophageal cancer: clinical features and survival outcome
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Unexpected diagnosis of synchronous second primary cancers (SPC) complicates physicians’ decision-making because clinical details of squamous esophageal cancer (EC) patients with SPC have been limited. We evaluated clinical features and treatment outcomes of patients with synchronous SPC detected during the initial staging of squamous EC. Methods: We identified a total of 317 consecutive patients diagnosed with squamous EC. Relevant clinical and cancer-specific information were reviewed retrospectively. Results: EC patients with synchronous SPC were identified in 21 patients (6.6%). There were significant differences in median age (70 years vs. 63 years, p = 0.01), serum albumin level (3.3 g/dL vs. 3.9 g/dL, p < 0.01) and body mass index (20.4 kg/m2 vs. 22.8 kg/m2 , p = 0.01) between EC patients with and without SPC. Head and neck, lung and gastric cancers accounted for 18.2%, 22.7%, and 18.2% of SPC, respectively. Positron emission tomography-computed tomography (PET-CT) detected four cases (18.2%) of SPC that were missed on CT. Management plans were altered in 13 of 21 patients (61.9%) with detected SPC. Curative esophagectomy was attempted in 28.6% of EC patients with SPC (vs. 59.1% of patients without SPC; p = 0.006). EC patients with SPC had significantly lower 5-year survival than patients without SPC (10.6% vs. 36.7%, p = 0.008). Conclusions: Synchronous SPC were found in 6.6% of squamous EC patients, and PET-CT contributed substantially to the detection of synchronous SPC. EC patients with SPC had poor survival due to challenges of providing stage-appropriate treatment.
Abstract
Background/Aims: Unexpected diagnosis of synchronous second primary cancers (SPC) complicates physicians’ decision-making because clinical details of squamous esophageal cancer (EC) patients with SPC have been limited. We evaluated clinical features and treatment outcomes of patients with synchronous SPC detected during the initial staging of squamous EC. Methods: We identified a total of 317 consecutive patients diagnosed with squamous EC. Relevant clinical and cancer-specific information were reviewed retrospectively. Results: EC patients with synchronous SPC were identified in 21 patients (6.6%). There were significant differences in median age (70 years vs. 63 years, p = 0.01), serum albumin level (3.3 g/dL vs. 3.9 g/dL, p < 0.01) and body mass index (20.4 kg/m2 vs. 22.8 kg/m2 , p = 0.01) between EC patients with and without SPC. Head and neck, lung and gastric cancers accounted for 18.2%, 22.7%, and 18.2% of SPC, respectively. Positron emission tomography-computed tomography (PET-CT) detected four cases (18.2%) of SPC that were missed on CT. Management plans were altered in 13 of 21 patients (61.9%) with detected SPC. Curative esophagectomy was attempted in 28.6% of EC patients with SPC (vs. 59.1% of patients without SPC; p = 0.006). EC patients with SPC had significantly lower 5-year survival than patients without SPC (10.6% vs. 36.7%, p = 0.008). Conclusions: Synchronous SPC were found in 6.6% of squamous EC patients, and PET-CT contributed substantially to the detection of synchronous SPC. EC patients with SPC had poor survival due to challenges of providing stage-appropriate treatment.
참고문헌 (23)
- Koide N, "Oesophageal cancer associated with other primary cancers: a study of 31 patients", J Gastroenterol Hepatol, 12, pp.690~694 (1997)
- Nagasawa S, "Multiple primary malignant neoplasms in patients with esophageal cancer", Dis Esophagus, 13, pp.226~230 (2000)
- Poon RT, "Multiple primary cancers in esophageal squamous cell carcinoma:incidence and implications", Ann Thorac Surg, 65, pp.1529~1534 (1998)
- Shibuya H, "The relation between an esophageal cancer and associated cancers in adjacent organs", Cancer, 76, pp.101~105 (1995)
- Chuang SC, "Risk of second primary cancer among patients with head and neck cancers:a pooled analysis of 13 cancer registries", Cancer Epidemiol Biomarkers Prev, 17, pp.1543~1549 (2008)
- Matsubara T, "Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus", J Clin Oncol, 21, pp.4336~4341 (2003)
- 박은경, "다발성 원발암의 임상고찰", 대한내과학회지, 69(4), pp.410~418 (2005), 대한내과학회
- fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging, "J Clin Oncol", 2005, 7654~7659
- Ishimori T, "Detection of unexpected additional primary malignancies with PET", CT, 2005, pp.46, 752~757
- van Westreenen HL, "Synchronous primary neoplasms detected on 18F-FDG PET in staging of patients with esophageal cancer", J Nucl Med, 46, pp.1321~1325 (2005)
- Warren S, "Multiple primary malignant tumors", Am J Cancer, 16, pp.1358~1414 (1932)
- Greene F, "AJCC Cancer Staging Manual" (2002), Springer-Verlag
- Ajani J, "Esophageal cancer: clinical practice guidelines in oncology", J Natl Compr Canc Netw, 1, pp.14~27 (2003)
- Kim JH, "Preoperative hyperfractionated radiotherapy with concurrent chemotherapy in resectable esophageal cancer", Int J Radiat Oncol Biol Phys, 50, pp.1~12 (2001)
- Lee JL, "A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma", Ann Oncol, 15, pp.947~954 (2004)
- Kim MK, "Treatment outcome and recursive partitioning analysis-based prognostic factors in patients with esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy", Int J Radiat Oncol Biol Phys, 71, pp.725~734 (2008)
- Gandini S, "Tobacco smoking and cancer: a meta-analysis", Int J Cancer, 122, pp.155~164 (2008)
- van Westreenen HL, "Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer", J Clin Oncol, 22, pp.3805~3812 (2004)
- Rosenbaum SJ, "Staging and follow-up of gastrointestinal tumors with PET", CT, 2006, pp.31, 25~35
- Kleinberg L, "Chemoradiation in the management of esophageal cancer", J Clin Oncol, 25, pp.4110~4117 (2007)
- 김용진, "수술이 불가능한 식도암에서 동시 항암화학방사선요법의효과", 대한내과학회지, 72(1), pp.37~43 (2007), 대한내과학회
- Lee GD, "Esophageal cancer associated with multiple primary cancers: surgical approaches and long-term survival", Ann Surg Oncol, 20, pp.4260~4266 (2013)
- Di Fiore F, "Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer", Am J Gastroenterol, 102, pp.2557~2563 (2007)